UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Amendment No. 2)*
Under the Securities Exchange Act of 1934
National Health Laboratories, Inc.
______________________________________
(Name of Issuer)
Common Stock
______________________________________
(Title of Class of Securities)
63633F-10-9
______________________________________
(CUSIP Number)
Check the following box if a fee is being paid with this statement . (A
fee is not required only if the filing person: (1) has a previous statement
on file reporting beneficial ownership of more than five percent of the
class of securities described in Item 1; and (2) has filed no amendment
subsequent thereto reporting beneficial ownership of five percent or less of
such class.) (See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
Page 1 of 4 pages
PAGE
<PAGE>
CUSIP NO. 63633F-10-9
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
GEICO Corporation
52-1135801
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) ____
(b) ____
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF 5. SOLE VOTING POWER
SHARES 6,404,000
BENEFICIALLY
OWNED BY 6. SHARED VOTING POWER
EACH - 0 -
REPORTING
PERSON 7. SOLE DISPOSITIVE POWER
WITH 6,404,000
8. SHARED DISPOSITIVE POWER
- 0 -
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
6,404,000
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.00%
12. TYPE OF REPORTING PERSON*
HC, EP
*SEE INSTRUCTION BEFORE FILLING OUT
Page 2 of 4 pages
PAGE
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Amendment No. 2
Under the Securities Exchange Act of 1934
Item 1. (a) Name of Issuer: National Health Laboratories Holdings, Inc.
(b) Address of Issuer's Principal 4225 Executive Square,
Executive Offices: Suite 800
La Jolla, California 92037
Item 2. (a) Name of Person Filing: GEICO Corporation
(b) Address of Principal GEICO Plaza
Business Office: Washington, D.C. 20076
(c) Citizenship: Delaware
(d) Title of Class of Common Stock
Securities:
(e) CUSIP No.: 63633F-10-9
Item 3. The person filing is a: Parent Holding Company
Item 4. Ownership*
(a) Amount Beneficially owned: 6,404,000 Shares
(b) Percent of Class: 7.00%
(c) Number of (i) Sole power to vote or to
shares as direct the vote: 6,404,000
to which
such person (ii) Shared power to vote or to
has: direct the vote: -0-
(iii) Sole power to dispose or to
direct the disposition of: 6,404,000
(IV) Shared power to dispose or to
direct the disposition of: -0-
* The number of shares beneficially owned and the percentage ownership
are as of December 31, 1994
Page 3 or 4 pages
<PAGE>
Item 5. Ownership of 5 Percent or Less of a Class: N/A
Item 6. Ownership of More than 5 Percent on Behalf of
Another Person: N/A
Item 7. Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported on by the
Parent Holding Company:
Of the shares reported in this Schedule,
750,000 are owned beneficially by the
GEICO Companies Pension Trust, a pension
fund which is subject to the require-
ments of the Employee Retirement Income
Security Act of 1974, and which is enti-
tled to receive the dividends on or pro-
ceeds from the sale of such securities.
Item 8. Identification and Classification of Members of
the Group: N/A
Item 9. Notice of Dissolution of Group: N/A
Item 10. Certification.
By signing below I certify that, to the best
of my knowledge and belief, the securities referred
to above were acquired in the ordinary course of
business and were not acquired for the purpose of
and do not have the effect of changing or
influencing the control of the issuer of such
securities and were not acquired in connection with
or as a participant in any transaction having such
purpose or effect.
Signature.
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the
information set forth in the statement is
true, complete and correct.
GEICO Corporation
By: /s/ Charles R. Davies
Charles R. Davies
Vice President and
General Counsel
Date:February 14, 1995 Charles R. Davies, Vice President and
General Counsel
Page 4 of 4 pages
